Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

2021/11/11
Clinical Development Updates on Medigen's MVC-COV1901 in COVID-19 Solidarity Trial Vaccines
see more
2021/10/27
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
see more
2021/10/15
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine
see more
2021/08/23
Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine MVC-COV1901 Adjuvanted with Dynavax's CpG 1018 Adjuvant
see more
2021/07/20
MVC Announces Paraguay Approval of IND Application for Phase 3 Clinical Trial
see more
2021/07/19
MVC COVID-19 Vaccine Obtains Taiwan EUA Approval
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree